Immatics N.V.
IMTX
|
NASDAQ
|
0 Followers
Company Quality
Profitability Score
29/100
Solvency Score
75/100
Dividends
Dividends data currently unavailable.Earnings
8/11/2025
in 53 days
-
Revenue est.
-
EPS est.
My Notes
You haven't added any notes for this stock yet. Use this space to record your insights or strategies.
Profile
Healthcare
Sector
Biotechnology
Industry
Dr. Harpreet Singh Ph.D.
CEO
554
Employees
Tübingen
Headquarters
DE
Country
Key Metrics TTM
Valuation
Market cap.
$649MEnterprise Value
$429MPrice to Earnings
37.19Price to Sales
4.17Price to Book
0.98Price to Cash Flow
-3.72Profitability
Return on Assets
2.18%Return on Equity
3.48%Return on Invested Capital
-4.37%Gross Margin
79.36%Operating Margin
-24.81%Net Margin
9.74%Liquidity
Quick Ratio
9.26Current Ratio
9.26Cash Ratio
3.48Inventory Turnover
0.00Asset Turnover
0.22Total Liabilities
$121MSolvency
Debt to Assets
0.02Debt to Equity
N/AInterest Coverage
-43.64Equity Ratio
0.83Long-term Debt to Cap.
0.00Altman Z-Score
3.09Performance
Earnings Waterfall
Debt level and coverage
Earnings
Feed
There are no posts to show right now.